Skip to main content
Premium Trial:

Request an Annual Quote

Daniel Farkas

Celmatix has appointed Daniel Farkas chief clinical laboratory officer for its new laboratory in Brooklyn, New York. He will be using his experience to lead the development of the new laboratory, which will conduct sequencing for the firm's genetic panel for fertility disorders.

Farkas has decades of experience in molecular diagnostics. He most recently worked as the lead laboratory director at Sequenom's clinical reference laboratories in San Diego; Grand Rapids, Michigan; and Morrisville, North Carolina. He has also served as president of the Association for Molecular Pathology; was the first professional to be certified in molecular diagnostics by the American Board of Bioanalysis; and has helped establish best practices in molecular pathology through his tenure on the College of American Pathologists' Molecular Pathology Resource Committee. 

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.